Between January and March 2018, Russia imported 2.7 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 42.8% higher than that of the same period of 2017. In physical terms, the import amounted to 40.5 mln units, which is 22.7% lower than that of the same period of 2017.

In March 2018, Russia imported 1.73 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 220% higher than that of March 2017. In physical terms, it is 17.9 mln units, which is 25.2% lower than that of March 2017.,/p>

As of March 2018, the absolute leader in monetary terms is Kelun-Kazpharm (Kazakhstan), which accounts for 39% of the total import. Its import has increased b 4.5 times over the year. It is followed by Belmedpreparaty and Borimed (Belarus), with 27% and 18% of the total import.

Chimpharm (Kazakhstan) has the best dynamics, with a 20.5 times increase. The total import from Kazakhstan to Russia has risen by 5 times since January 2018.

Metronidazolum is the most imported drug, it accounts for nearly 18% of the import in monetary terms and has the best dynamics. It is followed by Ciprofloxacinum (16.4%), Both Metronidazolum and Ciprofloxacinum are mainly imported by Kelun-Kazpharm. In physical terms, the leader is Cyanocobalamin, with a 2 times increase over the year. It is imported by Yerevan Chemical and Pharmaceutical Company, its import to Russia has increased by 15 times over the year.

Volume and dynamics of pharmaceutical drug import from EUU countries to Russia (wholesale prices, VAT included) (2016 – 2017, Q1 2018)